Ashcroft Pharmacy now offers Wegovy HD 7.2 mg a new, higher-dose formulation designed to support greater weight loss
Researchers caution against rapid weight loss as it is associated with loss of lean muscle mass alongside body fat if GLP-1 is not combined with adequate strength training and protein intake
While the currently approved GLP-1 therapies have transformed obesity management, they represent only the first wave of innovation
Search filters for sorting RCTs or clinical trials were applied to each database
We discuss the latest evidence that highlights tight junction components, structures and regulatory mechanisms, their impact on gut health and disease, and opportunities for therapeutic intervention
While this represents a tremendous social good, it also poses risks to the business structures of modern pharmaceutical companies